| Characteristic | Opioid dispensing rate per 100 persons |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
November 2024
North America, United States
2006 to 2023
"Source for all dispensing data: IQVIA Xponent 2006–2020. IQVIA Xponent is based on a sample of approximately 50,400 retail (non-hospital) pharmacies, which dispense nearly 92% of all retail prescriptions in the United States. For this database, a prescription is a new or refill prescription dispensed at a retail pharmacy in the sample and paid for by commercial insurance, Medicaid, Medicare, cash or its equivalent, and other third-party coverage. This database does not include mail order prescriptions."
"Source for all dispensing data: IQVIA Xponent 2019–2023. IQVIA Xponent is based on a sample of approximately 54,600 retail (non-hospital) pharmacies, which dispense nearly 94% of all retail prescriptions in the United States. For this database, a prescription is a new or refilled prescription dispensed at a retail pharmacy in the sample and paid for by commercial insurance, Medicaid, Medicare, cash or its equivalent, and other third-party coverage. This database does not include mail-order prescriptions. Geographic location is based on the location of the prescriber. Methadone dispensed through methadone treatment programs is not included in the IQVIA Xponent data."
